Levodropropizine

Chemical formula: C₁₃H₂₀N₂O₂  Molecular mass: 236.315 g/mol  PubChem compound: 65859

Active ingredient description

Levodropropizine is a drug provided with a mainly peripheral tracheobronchial antitussive effect together with an antiallergic and antibronchospastic effect.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
R05DB27 Levodropropizine R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DB Other cough suppressants
Discover more medicines within R05DB27

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 99291-25-5
DrugBank Drug: DB12472
PubChem Compound: 65859
RxNorm Ingredient: 52014
SNOMED-CT Concept: 697999004
Levodropropizine (substance)
UNII Identifier: 3O31P6T4G3
LEVODROPROPIZINE

Medicines

Levodropropizine is an active ingredient of these brands:

Brazil (BR)

Ecuador (EC)

Estonia (EE)

Hong Kong (HK)

Lithuania (LT)

Mexico (MX)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈